The DOI matches its Crossref record.
Deleterious Effects of Anabolic Steroids on Serum Lipoproteins, Blood Pressure, and Liver Function in Amateur Body Builders
Abstract
The effects of self-administered anabolic steroids (AS) on lipoproteins, liver function, and blood pressure were studied in male amateur body builders. Twenty body builders were studied at the end of a course of AS (group 1) and 42 body builders were studied after discontinuation of the AS for a mean of 5 months (group 2). Sixteen body builders were studied after discontinuation of AS for at least 2 months and at the end of a 9-week course of AS (group 3). A group of 13 body builders who never used AS served as a control group. Both groups 1 and 2 showed higher levels of transaminas and a higher systolic blood pressure than the controls (P less than 0.05). Group 3 showed an increase of the transaminases an a slight but significant increase of systolic blood pressure (+3 mm Hg) and heart rate (+7 bts/min) after one course of AS (P less than 0.05). Group 1 showed a considerably lower high-density lipoprotein cholesterol (HDLC) (P less than 0.001), a higher low-density lipoprotein cholesterol (LDLC) (P less than 0.05), and a lower apoprotein A-l/B ratio (Apo A-l/ApoB) (P less than 0.001) than the controls and group 2. The ratio of LDLC/HDLC in group 1 was fourfold higher than in the controls (P less than 0.01). In group 3 HDLC decreased from 1.18 +/- 0.05 to 0.60 +/- 0.08 mmol/l (P less than 0.001) and LDLC increased from 3.97 +/- 0.39 to 5.74 +/- 0.71 mmol/l (P less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Effects of Androgenic-Anabolic Steroids in Athletes
Hartgens, F., & Kuipers, H. (2004) · Sports Medicine · doi:10.2165/00007256-200434080-00003 · Cited by 873
Olivardia, R., Pope, H. G., Borowiecki, J. J., & Cohane, G. H. (2004) · Psychology of Men & Masculinity · doi:10.1037/1524-9220.5.2.112 · Cited by 614
Pope, H. G. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950050035004 · Cited by 604
Pursuit of the muscular ideal: physical and psychological consequences and putative risk factors
Cafri, G., Thompson, J. K., Ricciardelli, L., McCabe, M., Smolak, L., & Yesalis, C. (2005) · Clinical Psychology Review · doi:10.1016/j.cpr.2004.09.003 · Cited by 504
Shahidi, N. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80114-4 · Cited by 429
Kanayama, G., Hudson, J. I., & Pope, H. G. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.05.004 · Cited by 404
Use of doping agents, particularly anabolic steroids, in sports and society
Sjöqvist, F., Garle, M., & Rane, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60801-6 · Cited by 351
The cardiac toxicity of anabolic steroids
Sullivan, M. L., Martinez, C. M., Gennis, P., & Gallagher, E. J. (1998) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(98)80019-4 · Cited by 342
Olivardia, R. (2001) · Harvard Review of Psychiatry · doi:10.1080/10673220127900 · Cited by 278
Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?
Urhausen, A., Albers, T., & Kindermann, W. (2004) · Heart · doi:10.1136/hrt.2003.015719 · Cited by 275
Achar, S., Rostamian, A., & Narayan, S. M. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.05.013 · Cited by 265
Illicit anabolic–androgenic steroid use
Kanayama, G., Hudson, J. I., & Pope, H. G. (2010) · Hormones and Behavior · doi:10.1016/j.yhbeh.2009.09.006 · Cited by 257
Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease
Rodino‐Klapac, L. R., Haidet, A. M., Kota, J., Handy, C., Kaspar, B. K., & Mendell, J. R. (2009) · Muscle & Nerve · doi:10.1002/mus.21244 · Cited by 194
Vicencio, J. M., Ibarra, C., Estrada, M., Chiong, M., Soto, D., Parra, V., Diaz-Araya, G., Jaimovich, E., & Lavandero, S. (2006) · Endocrinology · doi:10.1210/en.2005-1139 · Cited by 149
“It is known that there are increases in blood pressure and peripheral arterial resistance (4, 5), and there are also effects on the heart muscle, primarily left ventricular hypertrophy with restricted diastolic function (6–8).”
BackgroundCardiovascular Toxicities of Performance-Enhancing Substances in Sports
Dhar, R., Stout, C. W., Link, M. S., Homoud, M. K., Weinstock, J., & Estes, N. A. M. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.10.1307 · Cited by 122
Broeder, C. E., Quindry, J., Brittingham, K., Panton, L., Thomson, J., Appakondu, S., Breuel, K., Byrd, R., Douglas, J., Earnest, C., et al. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.20.3093 · Cited by 109
Illicit drugs and cardiac arrhythmias in athletes
Furlanello, F., Serdoz, L. V., Cappato, R., & De Ambroggi, L. (2007) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3280ecfe3e · Cited by 70
McCullough, D., Webb, R., Enright, K. J., Lane, K. E., McVeigh, J., Stewart, C. E., & Davies, I. G. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09616-y · Cited by 62
“By contrast, early studies suggested that AAS use did not have a detrimental effect on BP even with 24-hour monitoring [97, 106, 166].”
BackgroundResultInfluential
Metadata
- Authors
- Lenders, J., Demacker, P., Vos, J., Jansen, P., Hoitsma, A., van 't Laar, A., & Thien, T.
- Venue
- International Journal of Sports Medicine
- Publisher
- Georg Thieme Verlag KG
- Published
- 1988-02
- Volume
- 09
- Issue
- 01
- Pages
- 19-23
- ISSN
- 0172-4622 (ISSN-L)
- 1439-3964
- OpenAlex
- W1963813683
- Cited by
- 126
- References
- 0
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.